Kombiglyze XR Lawsuit

Kombiglyze XR Lawsuit Research shows that type 2 diabetes drug Kombiglyze XR (saxagliptin and metformin) may cause heart failure or other cardiovascular injuries in some patients. According to the Centers for Disease Control and Prevention (CDC), 30 million Americans have diabetes and 84 million have pre-diabetes. Metformin—one of the drugs found in combination drug Kombiglyze—is among the top 10 most popular prescription drugs taken by Americans. Analysts also predict that Onglyza (saxagliptin), Kombiglyze’s sister drug, could reach $1.8 billion in sales in 2018. ​ In 2015, roughly 386,000 people were prescribed Onglyza or Kombiglyze XR, the FDA reported. Given that so many people take these drugs, any side effects they may cause that are severe enough to hospitalize patients should be treated with concern. Dozens of patients are filing lawsuits against Kombiglyze’s manufacturer AstraZeneca and its previous partner Bristol-Myers Squibb alleging that the companies failed to adequately test the drugs’ safety prior to selling it, which ultimately caused their cardiovascular injuries. If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze lawsuit and possibly entitled to substantial compensation. https://www.classactionlawyertn.com/kombiglyze.html Follow up: https://www.facebook.com/timmileslaw https://twitter.com/TimMile83043830 https://www.linkedin.com/company/the-law-offices-of-timothy-l-miles https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ https://www.pinterest.com/tmiles676767/ https://www.instagram.com/10k_law/1

from
https://www.youtube.com/watch?v=zvCitBiRetA